非穿透性小梁切除术联合亲水丙烯酸填充引流器植入治疗开角型青光眼

目的：探讨非穿透性小梁切除术联合亲水丙烯酸填充引流器植入治疗开角型青光眼的效果和降眼奈的机制，开发一种国产生物胶植入引流器。方法：对16例（24只眼）开角型青光眼行NPTS联合亲水丙烯酸填充引流器植入治疗，术后随访2－6个月，平均4个月，分别进行眼奈，视力，滤过泡形态，视野等观察。结果：16例（24只眼）术前平均眼压（用药后）22－30．39mmHg，术后2个月平均眼压14．31017．01mmHg，6个月平均眼压15．02－18．52mmHg，结膜下形成滤过泡12例（18只眼），占75％，均未出现严重并发症，部分症例视力及视野较术前有所提高。房角检查，均可见手术区小梁网后有一减压伐存在，结论：NPTS联合亲水丙烯酸填充引流器植入治疗开角型青光眼是安全有效的，与进口的填充材料疗效相同，且价格低，是一种良好的巩膜瓣下填充引流材料。     

非穿透性小梁切除术联合人羊膜植入临床观察

目的：观察非穿透性小梁切除术联合人羊膜植入的临床效果。方法：对18例（30眼）中、晚期开角型青光眼进行非穿透性小梁切除术联合人羊膜植入，术后观察视力、视野、眼压及滤过泡形成情况。结果：术后随访3－9月，视力、视野稳定，眼压≤20mmHg(1mmHg=0.133kPa)，滤过泡形成良好，并发症少。结论：非穿透性小梁切除术 联合人羊膜植入治疗开角型青光眼，能有效降低眼压，形成功能性滤过泡和并发症少等优点，是治疗开角型青光眼较理想的方法。     

非穿透性小梁手术治疗原发性开角型青光眼的临床观察

目的探讨非穿透性小梁手术（NPTS）联合透明质酸钠生物胶植入的临床疗效。方法对32例（38眼）原发性开角型青光眼实施非穿透性小梁手术联合透明质酸钠生物胶植入术。观察术后视力、眼压、滤过泡、前房反应、前房深浅及并发症。术后随访（14．6±2．3）月。结果术前平均眼压（29．2±8．01）mmHg。术后1周平均眼压（15．01±4．65）mmHg,手术前后眼压差异有统计学意义。术后30眼前房无任何反应,2眼有I度浅前房伴少许前房积血,均术后2～3d自行恢复,6眼轻度房水闪光,术后2～3d消失。所有患眼术后均形成显著弥散滤过泡。术后1周及6月视力基本稳定。结论非穿透性小梁手术联合透明质酸钠生物胶植入治疗开角型青光眼疗效肯定,并发症少,为开角型青光眼提供了一种更安全的治疗方法。     

Ex-PRESS引流器植入治疗原发性开角型青光眼的疗效

目的：观察Ex-PRESS青光眼引流器植入治疗原发性开角型青光眼的临床疗效。

方法：原发性开角型青光眼患者41例54眼分为研究组和对照组。研究组19例25眼,行Ex-PRESS青光眼引流器植入; 对照组22例29眼,行小梁切除术。比较两组患者平均手术时间、术后视力、浅前房、眼压、滤过泡及其他并发症的情况。

结果：研究组手术时间34.60±4.43min,术后1d浅前房1眼、前房出血1眼; 术后1wk高眼压2眼; 术后3mo视力下降1眼、功能性滤过泡24眼、眼压11.5±5.8mmHg。对照组手术时间44.37±3.00min,术后1d浅前房13眼、前房出血渗出12眼; 术后1wk高眼压8眼; 术后3mo视力下降6眼、功能性滤过泡25眼、眼压13.6±6.7mmHg。研究组术后并发症较少,眼压控制更低,术后视力影响、功能性滤过泡与对照组相当。

结论：Ex-PRESS青光眼引流器植入治疗原发性开角型青光眼手术时间缩短,术后浅前房、前房出血渗出并发症少,安全性高,疗效好。     

非穿透性小梁手术治疗青少年开角型青光眼

目的探讨非穿透性小梁手术（NPTS）联合透明质酸钠生物胶（SK胶）植入治疗青少年开角型青光眼的临床疗效。方法对12例（22眼）青少年开角型青光眼采用非穿透性小梁手术联合SK胶植入,术中应用抗代谢药物。术后观察视力、眼压、滤过泡、眼底杯/盘、视野及手术并发症。随访36～44个月,并在末次随访时行超声生物显微镜（UBM）检查。结果手术1周及随访末次平均眼压分别为（10.27±1.38）mmHg,（16.18±7.69）mmHg,与术前平均眼压（29.38±12.56）mmHg相比,差异均有统计学意义（分别为t=6.65,P〈0.01和t=2.71,P〈0.01）。术后22眼均形成显著弥散滤过泡,末次随访时10眼（45.50%）可见扁平稍弥散滤过泡,12眼（54.50%）手术区瘢痕形成,未见滤过泡;视力提高2行及以上者5眼,不变者17眼,无视力下降。眼底杯/盘减小者6眼,不变者16眼;视野改善者6眼,不变者16眼,无视野损害进行性加重。结论非穿透性小梁手术联合透明质酸钠生物胶植入治疗青少年开角型青光眼疗效确切,并发症少,可作为青少年开角型青光眼的首选术式。     

非穿透性小梁手术联合羊膜移植治疗开角型青光眼

目的 :探讨非穿透性小梁手术 (NPTS)联合羊膜移植治疗开角型青光眼的机制及疗效评价。寻找透明质酸钠凝胶植入材料替代物。方法 :对 18例 2 5只开角型青光眼患者行非穿透性小梁手术联合羊膜移植 ,术后观察视力、眼压、滤过泡及眼内反应 ,随访时间最短 30天 ,最长 4 2 0天。结果 :术前 2 5只眼平均眼压为 (38 2± 14 4 )mmHg ,2 5只眼术后 3只眼眼压高于 2 1mmHg ,经降眼压药物治疗后 2只眼仍高达 2 8mmHg以上 ,余眼压均控制在 7～ 2 0mmHg之内 ,术后 2个月手术成功率为 88% ,条件成功率为 92 % ,术后 3个月手术成功率为 82 % ,条件成功率为 88%。术后视力均有显著提高 ,滤过泡扁平弥漫 ,轻微充血。术中、术后未出现浅前房、前房出血、玻璃体脱出、脉络膜脱离等并发症。结论 :非穿透性小梁手术联合羊膜移植能安全、有效地降低眼压 ,为非穿透性小梁手术提供了有效安全植入材料。可广泛用于开角型青光眼的治疗     

非穿透性小梁切除術聯合親水丙烯酸填充引流器植入治療開角型青光眼

目的探討非穿透性小梁切除術聯合親水丙烯酸填充引流器植入治療開角型青光眼的效果和降眼壓的機制,開發一種國產生物植入引流器.方法對16例(24祗眼)開角型青光眼行NPTS聯合親水丙烯酸填充引流器植入治療,術後隨訪2～6個月,平均4個月,分别進行眼壓、視力、滤過泡形態、視野等觀察.結果16例(24祗眼)術前平均眼壓(用藥後)22～30.39mmHg;術後2個月平均眼壓14.31～17.01mmHg,6個月平均眼壓15.02～18.52mmHg.結膜下形成滤過泡12例(18祗眼),占75%,均未出現嚴重并發癥,部分病例視力及視野較術前有所提高.房角檢查,均可見手術區小梁綱後有一减壓閥存在.結論NPTS聯合親水丙烯酸填充引流器植入治療開角型青光眼是安全有效的,與進口的填充材料療效相同.且價格低,是一種良好的鞏膜瓣下填充引流材料.     

青光眼引流器植入联合小梁切除术治疗难治性青光眼的临床观察

目的：观察青光眼引流器植入联合小梁切除术治疗难治性青光眼的疗效。方法对34例（46只眼）难治性青光眼行青光眼引流器植入联合小梁切除术治疗,观察术后视力、眼压、滤过泡及并发症等情况。结果34例难治性青光眼中,新生血管性青光眼12例（17只眼）,无晶状体眼4例（4只眼）,人工晶状体眼1例（1只眼）,外伤性青光眼2例（2只眼）,发育性青光眼9例（12只眼）,色素播散性青光眼2例（2只眼）。术前平均眼压（42．15±2．32）mmHg,术后眼压控制30只眼,眼压部分控制7只眼,眼压失控9只眼,术后平均眼压（18．34±3.55）mmHg,眼压有效控制率为80．43％。功能性滤过泡形成率67．39％,手术并发症较少。结论新型国产青光眼引流器植入联合小梁切除术治疗难治性青光眼疗效好,安全性高,术后并发症少,可以推广使用。     

非穿透性小梁手术联合醛化脐带静脉管植入及MMC治疗POAG

目的:评价非穿透性小梁手术(non-penetrating trabecular surgery,NPTS)联合醛化脐带静脉管(human umbilical vein,HUV)植入和丝裂霉素C(mitomycin C,MMC)治疗原发性开角型青光眼(primary open angle glaucoma,POAG)的临床疗效。方法:对42例42眼POAG患者进行NPTS联合HUV植入和MMC治疗。术后观察指标包括:术后眼压、术后抗青光眼药物应用、术后滤过泡形态学以及术后并发症,随访时间12mo。结果:术后12 mo,手术完全成功81%,条件成功95%;眼压从术前(26.1±7.7)mmHg降至(15.3±3.8)mmHg(P=0.00);抗青光眼药物从术前(3.2±0.5)种减少到(0.3±0.2)种(P=0.00);滤过泡形态,Ⅰ型滤过泡26%,Ⅱ型滤过泡59%,Ⅳ型滤过泡14%。术后6眼出现包裹性滤过泡,3眼有轻微前房出血,无浅前房、低眼压和脉络膜脱离等并发症发生。结论:NPTS联合HUV植入和MMC治疗POAG,具有手术成功率高,术后IOP控制良好,术后并发症发生率低的特点。     

小梁切除联合青光眼引流器植入治疗青光眼疗效观察

目的观察青光眼小梁切除联合青光眼引流器植入并可调整缝线术治疗青光眼的临床效果。方法9例（15眼）行小梁切除联合青光眼引流器植入并可调整缝线术。观察术后视力、眼压、眼底、视野、滤过泡、前房深度及并发症情况。术后随访12～24个月。结果M眼术后眼压维持在10～20mmHg之间,眼压控制成功率为93．33％,1例（1眼）随访半年后失去联系。术后视力、视野和C／D比值与术前相同。I型微小囊状型5眼,Ⅱ型弥漫扁平型10眼,无浅前房、脉络膜脱离或眼内炎等并发症。结论小梁切除联合青光眼引流器植入并可调整缝线术能有效地降低眼压,可以延长滤过泡功能,减少瘢痕形成,并减少低眼压出现,提高滤过性手术的成功率。     

合并成型性渗出的急性前葡萄膜炎与HLA-B27的相关性研究

目的 探讨急性渗出性前葡萄膜炎与HLA-B27的相关性。方法 对53例前房内出现成型性渗出的急性前葡萄膜炎（AAUPE）患者及61例前房内无成型性渗出的急性前葡萄膜炎（AAU）患者进行HLA-B27的检测,并结合临床表现加以分析。结果 成型性渗出的AAUPE患者的HLA-B27阳性率为100％,而无成型性渗出的AAU患者的HLA-B27阳性率仅为50.8％。二者有显著差异性（P<0.01）。两组HLA-B27阳性的病人强直性脊柱炎发生率分别为50.0％和42.9％。结论 结果进一步证实了HLA-B27与成型性渗出密切相关的论点。提示检测AAU患者HLA-B27的阳性率,发现成型性渗出裂隙灯检查似与血清法检测同样准确。     

The efficacy of treating patients with intraocular hemorrhages with emoxypin

Emoxipin, a home-made preparation approved by the Pharmacological Committee for clinical usage in 1986, is a retinal protector. Its usage is indicated for treatment of chorioretinitis, diabetic retinopathy, thrombosis of retinal vessels as well as to protects the retina from a damaging action of light of high intensity. In order to study therapeutic effectiveness of emoxipin in intraocular hemorrhages of different genesis, the preparation was used subconjunctivally, 0.5 ml of a 1% solution daily for 10-15 days. Emoxipin was used in 29 patients (29 eyes) with intraocular hemorrhages, of them, due to contusion of the eye--in 19, hypertonic disease--in 6, thrombosis of the central retinal vein--in 2, after intraocular operations--in 2 patients. As a result of the treatment, partial or almost total resolution of hemorrhages and a rise of visual acuity of different degree were recorded in all patients. Before treatment, visual acuity was from light perception to 0.04 in 26 eyes, from 0.09 to 0.3 in 3 eyes. After treatment, it rose to 0.1-0.2 in 12 eyes, to 0.3-1.0--in 17 eyes.     

A case of hypertensive keratouveitis with endotheliitis associated with cytomegalovirus

AIM: While cytomegalovirus is well known as a pathogenic organism of retinitis, especially associated with human immunodeficiency virus infection, there are few reports of anterior uveitis associated with cytomegalovirus. METHODS: The authors present a case of keratouveitis associated with cytomegalovirus. RESULTS: A 70-year-old Japanese man was referred to the authors because of poorly controlled hypertensive keratouveitis in the left eye. The patient had a history of recurrent hypertensive anterior uveitis. At presentation, the corneal stroma was edematous, with Descemet's folds and pigmented keratic precipitates. The anterior chamber angle was depigmented compared to the fellow eye. Even though pupil dilation and posterior synechiae were absent, iris atrophy was not evident. His right eye appeared normal except for moderate cataract. Funduscopy of the left eye was hazy, with the optic disc showing a normal color but poorly defined details, and no apparent exdative retinitis. The best-corrected decimal visual acuity of the right and left eyes was 0.4 and 0.02, respectively. Intraocular pressure was 11 mmHg in the right eye and 35 mmHg in the left, despite maximum medical therapy. Systemic acyclovir and prednisolone for a month did not improve the hypertensive keratouveitis. The aqueous humor was investigated for herpes simplex virus, varicella-zoster virus and cytomegalovirus. Cytomegalovius genome was detected by polymerase chain reaction analysis. Oral valganciclovir rapidly reduced ocular hypertension within a week. CMV DNA disappeared 3 months after the initiation of valganciclovir. CONCLUSION: The authors reported a case of hypertensive keratouveitis with endotheliitis associated with cytomegalovirus.     

Angiolymphoid hyperplasia with eosinophilia of the eyelid with spontaneous regression

A 53-year-old Chinese man presented with a painless left upper eyelid lump of 2 weeks' duration. Histopathology was consistent with angiolymphoid hyperplasia with eosinophilia, and also revealed neutrophilic infiltrate secondary to ulceration. After incisional biopsy, the residual lesion, which was not treated, developed surface keratinization over the next 2 weeks and sloughed off, leaving intact epidermis and no scar. This case illustrates that observation awaiting spontaneous regression may be considered prior to surgical and other therapeutic interventions. The authors also briefly review the literature on angiolymphoid hyperplasia with eosinophilia and Kimura disease, with emphasis on ocular involvement.